The WACC of Inozyme Pharma Inc (INZY) is 9.7%.
| Range | Selected | |
| Cost of equity | 9.80% - 12.80% | 11.30% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 8.5% - 10.8% | 9.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.29 | 1.41 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.80% | 12.80% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.27 | 0.27 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 8.5% | 10.8% |
| Selected WACC | 9.7% | |